Innocan Pharma Corp. buy Indyro
Start price
15.09.21
/
80%
€0.70
Target price
15.09.22
€2.00
Performance (%)
-41.34%
End price
17.05.22
€0.41
Summary
This prediction ended on 17.05.22 with a price of €0.41. Massive losses of -41.34% were the result for the BUY prediction by Indyro. Indyro has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Innocan Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 0,61 % | 0,34 % | 12,06 % | 58,10 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % | 1,74 % | 84,36 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % | 27,39 % | 64,84 % |
| iShares S&P 500 | 0,54 % | -0,70 % | 1,91 % | 58,67 % |
Comments by Indyro for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy Innocan Pharma Corp.